Photo of Jerónimo Rafael Rodríguez Cid from Oncologia.mx
Jul 10, 2024, 09:39
Jerónimo Rafael Rodríguez Cid: A secondary analysis from MARIPOSA
Jerónimo Rafael Rodríguez Cid, Medical Oncologist at CDMX shared a post on X:
“We published this analysis of the Mariposa trial that shows the influence of p53 gene in patients with EGFR genetic alteration lung cancer treated with amivantamab versus osimertinib. We will never stop trying/Nunca dejaremos de intentarlo.”
Source: Jerónimo Rafael Rodríguez Cid/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 16:16
Feb 22, 2025, 16:04
Feb 22, 2025, 16:00
Feb 22, 2025, 15:54
Feb 22, 2025, 15:48
Feb 22, 2025, 15:33
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10